MedTrace Logo

Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

NCT05151510 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2026-02-13

No results posted yet for this study

Summary

The aim of this trial is to investigate the efficacy of trigger point injections with 1% lidocaine in reducing myofascial back and neck pain in the Emergency Department compared to lidocaine patches 5%.

Conditions

  • Myofascial Trigger Point Pain
  • Myofacial Pain

Interventions

PROCEDURE

Trigger point injection with 1% lidocaine

Previously discussed in prior section.

DRUG

Lidocaine patch 5%

Will place lidocaine patch onto skin overlaying point of maximal tenderness

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Jonathan Lee, MD · UCI Department of Emergency Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-06-30
Completion
2022-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05151510 on ClinicalTrials.gov